MXD1

Across TCGA pan-cancer cohorts, MXD1 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MXD1 data layer compared with 23 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher MXD1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated MXD1 expression acts as an unfavorable survival marker.

PDAC are the cancer types where MXD1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Tertile	All	0.190	0.718	.001	31	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

MXD1–PDAC (DFS)

Open the PDAC breakdown →